Provided by Tiger Trade Technology Pte. Ltd.

Exelixis

41.82
+0.75001.83%
Volume:1.02M
Turnover:42.77M
Market Cap:10.86B
PE:15.04
High:42.13
Open:41.36
Low:41.24
Close:41.07
52wk High:49.62
52wk Low:32.38
Shares:259.71M
Float Shares:223.00M
Volume Ratio:0.46
T/O Rate:0.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.78
EPS(LYR):2.78
ROE:35.53%
ROA:19.27%
PB:5.03
PE(LYR):15.04

Loading ...

Assessing Exelixis (EXEL) Valuation After Analysts Lift 2026 Earnings Forecasts

Simply Wall St.
·
Mar 13

Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), Hims & Hers Health (HIMS) and Regeneron (REGN)

TIPRANKS
·
Mar 09

A Look At Exelixis (EXEL) Valuation As Analyst Optimism Builds Around Its Oncology Pipeline

Simply Wall St.
·
Mar 05

Exelixis Is Maintained at Sector Perform by RBC Capital

Dow Jones
·
Mar 03

Exelixis price target lowered to $43 from $46 at RBC Capital

TIPRANKS
·
Mar 02

RBC Lowers Price Target on Exelixis to $43 From $46, Keeps Sector Perform Rating

MT Newswires Live
·
Mar 02

RBC Capital Sticks to Its Hold Rating for Exelixis (EXEL)

TIPRANKS
·
Mar 02

Exelixis: Welireg Competition Tempers RCC Upside but Embedded Cabozantinib Franchise Supports Hold Rating

TIPRANKS
·
Mar 02

Crocs, Linde, Zillow, Exelixis, Qorvo: Insider Cash-Outs

TIPRANKS
·
Feb 28

Exelixis to Webcast Fireside Chats at Upcoming Investor Conferences

Reuters
·
Feb 25

Exelixis EVP of Research and Development Aftab Dana Disposes of Common Shares

Reuters
·
Feb 24

Exelixis Director Jack L Wyszomierski Disposes of Common Shares

Reuters
·
Feb 21

Exelixis Director Sue Gail Eckhardt Disposes of Common Shares

Reuters
·
Feb 19

Exelixis SVP and General Counsel Brenda Hefti Disposes of Common Shares

Reuters
·
Feb 19

RBC Capital Keeps Their Hold Rating on Exelixis (EXEL)

TIPRANKS
·
Feb 19

Exelixis Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Feb 12

Exelixis: Solid Financial Beat and Advancing Oncology Pipeline Drive Upgraded Earnings Outlook and $54 Price Target

TIPRANKS
·
Feb 12

Exelixis price target raised to $54 from $52 at H.C. Wainwright

TIPRANKS
·
Feb 12

Exelixis, Inc. : H.c. Wainwright Raises Target Price to $54 From $52

THOMSON REUTERS
·
Feb 12

Exelixis Earnings Call: CABOMETYX Strength, ZANZA Catalyst

TIPRANKS
·
Feb 12